tobramycin inhalation solution / Joincare - LARVOL DELTA

Application of inhaled tobramycin in the treatment of severe pneumonia patients with mechanical ventilation: a randomized, double-blind, parallel controlled, exploratory study (ChiCTR) - P4 | N=104 | Not yet recruiting | Sponsor: The Affiliated Hospital of Medical College Qingdao University, China; The Affiliated Hospital of Medical College Qingdao University, China

New P4 trial • Infectious Disease • Pneumonia • Respiratory Diseases

Study on Serum and Pulmonary Drug Concentrations, Pharmacokinetics/Pharmacodynamics, and Efficacy Evaluation of Long-Term Tobramycin Inhalation Solution Regimen in Bronchiectasis Patients with Pseudomonas aeruginosa Infection (ChiCTR) - P4 | N=24 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Guangzhou Medical University; Joincare Pharmaceutical Group Industry Co.,Ltd

New P4 trial • Bronchiectasis • Infectious Disease • Pulmonary Disease • Respiratory Diseases

Cost-effectiveness analysis of two inhaled antibiotics for stable Bronchiectasis with Pseudomonas aeruginosa infections in China. (PubMed, PLoS One) - "TIS reduces healthcare costs and improves clinical outcomes compared to CMS in managing BE with PA infections in China. This study supports the inclusion of TIS in clinical guidelines for managing BE with PA infections, considering both economic benefits and health outcomes."

HEOR • Journal • Bronchiectasis • Infectious Disease • Pulmonary Disease • Respiratory Diseases